Organigram Global Inc
Organigram Global Inc. is a Canadian cannabis company with operations centered on licensed cultivation, processing, and branded cannabis products through Organigram Inc. and related subsidiaries. The company also participates in medical cannabis and cannabinoid beverage markets in Canada, the United States, Germany, and selected other international markets through acquisitions and brand development.
Liiketoiminta
Osuus liikevaihdostaCannabis flower produced at licensed cultivation facilities for adult-use and related markets.
Processed cannabis products including minor-cannabinoid formulations and infused pre-rolls.
Cannabis edibles and cannabinoid beverages sold under company and acquired brands.
Medical cannabis products and brand offerings in Germany and other regulated markets.
Labelling, packaging, and national fulfillment services supporting product distribution.
Asiakkaat
Organigram sells primarily into regulated cannabis channels, including adult-use consumers, medical cannabis patients, and wholesale or channel partners that distribute branded products. Its beverage and derivative products also address cannabinoid consumers in Canada and, through acquired businesses, in the U.S. and Europe. The customer base is shaped by local regulations, retail access, and brand preference within each market.
Buy branded flower, pre-rolls, edibles, and derivative products for recreational use.
Buy medical cannabis products through regulated channels in Germany and Europe.
Buy cannabinoid beverages and related products through consumer channels.
Stock and distribute Organigram-branded products across regulated markets.
Strategia
Organigram's strategy centers on strengthening its branded cannabis portfolio, improving SKU productivity, and using its processing footprint to support higher-value derivative products. The company is also expanding beyond Canada through acquisitions and partnerships, especially in medical cannabis and cannabinoid beverages, to diversify growth drivers and build an international platform.
Fewer, better-performing SKUs can improve execution and production efficiency.
Non-Canadian markets can diversify revenue and reduce reliance on one market structure.
Edibles, beverages, and extracts can support brand differentiation and margin mix.
Maantiede
Organigram is headquartered in the United States for reporting purposes but operates predominantly in Canada, where its cultivation and processing facilities are located and Health Canada regulates the business. Through Sanity Group and other acquisitions, the company also has exposure to Germany, the United Kingdom, Australia, and additional international markets, making its footprint multi-market rather than purely domestic. Geography matters because cannabis rules, product formats, and customer access differ significantly across each market.
Riskit
Organigram is exposed to regulatory and market-structure risk because cannabis remains tightly controlled and market rules vary by country. The business also faces execution risk in integrating acquisitions, managing multi-site production, and maintaining product quality and brand relevance across a broad SKU portfolio.
- Cannabis regulatory changeVaikutus: KorkeaTodennäköisyys: Korkea
Sales and product formats depend on Health Canada and foreign market rules.
Kohdistuu - Acquisition integrationVaikutus: KorkeaTodennäköisyys: Kohtalainen
The business combines multiple entities, brands, and geographies that must be integrated.
Kohdistuu: Sanity Group and other acquired businesses
- Product and SKU complexityVaikutus: KeskitasoTodennäköisyys: Korkea
A large branded portfolio increases forecasting, production, and inventory risk.
Kohdistuu - International market executionVaikutus: KeskitasoTodennäköisyys: Kohtalainen
Growth outside Canada depends on local partners, approvals, and consumer uptake.
Kohdistuu
Kirjanpito
Harkinnanvaraiset erätThese instruments can create earnings volatility through remeasurement.
Vaikutus: Can materially affect reported losses and equity
Management estimates probable losses using judgment and updated information.
Vaikutus: May create expense reversals or additions in future periods
Sanity and other acquisitions require valuation of acquired assets and liabilities.
Vaikutus: Affects goodwill, intangibles, and future impairment exposure
Cannabis cultivation and processing require allocation of production costs across lots and SKUs.
Vaikutus: Can affect gross margin and period-to-period comparability
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Target Group Inc.
CBDY · Medicinal Chemicals & Botanical Products
CordovaCann Corp.
LVRLF · Services-Amusement & Recreation Services
Canopy Growth Corp
CGC · Medicinal Chemicals & Botanical Products
Canopy Growth Corp is a cannabis and hemp company built around medical cannabis brands, vaporizers, and a portfolio of U.S.
Cannapharmarx, Inc.
CPMD · Pharmaceutical Preparations
SNDL Inc.
SNDL · Medicinal Chemicals & Botanical Products
Ayr Wellness Inc.
AYRWF · Medicinal Chemicals & Botanical Products
Päivitetty: 28.9.2026